Stryker

SYK · NYSE

$304.40+$6.46 (+2.17%)TodayMarket closed ·
Prev close $297.94

Latest news

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into Stryker Corporation (SYK) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releaseGlobe Newswire

    Stryker Corporation (SYK) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into Stryker Corporation (SYK) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Press releasePRNewswire

    Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK

  • News

    10 Health Care Stocks With Whale Alerts In Today’s Session

  • NewsVandana Singh

    Stryker Makes $400 Million Robotic Surgery Bet

  • News

    10 Health Care Stocks With Whale Alerts In Today’s Session

  • Press releaseGlobe Newswire

    Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery

  • Press releasePRNewswire

    Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK

  • Press releasePRNewswire

    Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS

  • Press releaseGlobe Newswire

    Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS

  • Press releasePRNewswire

    Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™

  • Press releaseBusiness Wire

    Securities Fraud Investigation Into Stryker Corporation (SYK) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releaseBusiness Wire

    Stryker Corporation (SYK) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Press releaseBusiness Wire

    Securities Fraud Investigation Into Stryker Corporation (SYK) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Press releaseGlobe Newswire

    SYK ALERT: Stryker Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm

  • NewsPiero Cingari

    S&P 500, Nasdaq Slip as $98 Brent Reignites Inflation Fears: Stock Market Today

  • Press releasePRNewswire

    Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center

  • Press releasePRNewswire

    Providence™ Medical Technology Appoints Lane Major as President & Chief Executive Officer

  • NewsAvi Kapoor

    Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

  • News

    Correction: Stryker Q2 Adj. EPS $3.69 Beats $3.49 Estimate, Sales $6.589B Beat $6.579B Estimate

  • Press releaseGlobe Newswire

    Stryker reports second quarter 2026 operating results

  • NewsBamboo Works

    MicroPort MedBot To Report First-Ever Profit On Booming Exports

  • Press releasePRNewswire

    Stryker expands Mako robotics portfolio with full market release of Mako RPS

  • Press releasePRNewswire

    Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement

  • NewsAvi Kapoor

    Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO

  • Press releasePRNewswire

    Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower

  • Press releasePRNewswire

    Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

  • Press releaseBusiness Wire

    Stryker Launches Pangea Plating System and Completes First Case in Europe

  • Press releaseBusiness Wire

    BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

  • NewsTanya Rawat

    Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'

  • Press releaseGlobe Newswire

    Stryker reports first quarter 2026 operating results

  • Press releasePRNewswire

    Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)

  • Press releaseGlobe Newswire

    Stryker reports 2025 operating results and 2026 outlook

  • News

    Price Over Earnings Overview: Stryker

  • Press releaseBusiness Wire

    VB Spine Completes Acquisition of Cestas Manufacturing Facility from Stryker

  • NewsHillary Remy

    AI Integration In MedTech Devices And Diagnostics: Regulation And Investment Opportunities

  • News

    P/E Ratio Insights for Stryker

  • News

    P/E Ratio Insights for Stryker

  • Press releaseGlobe Newswire

    Stryker reports third quarter 2025 operating results

  • Press releaseGlobe Newswire

    Stryker reports second quarter 2025 operating results

  • News

    A Look Into Stryker Inc's Price Over Earnings

  • Press releaseGlobe Newswire

    Stryker reports first quarter 2025 operating results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.